Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213”
Sign Up to like & getrecommendations! Published in 2022 at "Medicina"
DOI: 10.3390/medicina58060793
Abstract: We appreciate Ahmed Sami Aljabali and his colleagues for their interest and comments [...]. read more here.
Keywords: reply aljabali; comment abbas; aljabali comment; safety efficacy ... See more keywords